Karuna Kumar: Busting the Myth about Increasing Infection Risk by IV Iron
Karuna Kumar, Senior Consultant at Yashoda Hospitals, shared a post on LinkedIn about a recent article by Paul W. Foley et al, published in European Journal of Heart Failure, adding:
“One concern I hear from colleagues about IV iron:
‘Doesn’t it increase infection risk? Iron feeds bacteria.’
Fair question. The theory makes sense. Iron is essential for bacterial growth. Give IV iron, maybe you’re feeding pathogens.
The IRONMAN trial just addressed this directly.
They looked at heart failure patients who received IV ferric derisomaltose vs standard care. Specifically tracked serious infections.
The finding?
No increased infection risk.
In fact, there was a trend toward fewer infections in the IV iron group. Not statistically significant, but certainly not worse.
The explanation:
Correcting iron deficiency actually improves immune function. Iron-deficient patients are more susceptible to infections, not less.
My practice hasn’t changed. I’ve been comfortable with IV iron for years. But now I have better data to share with patients who ask.
Based on current evidence, the infection concern appears to be theoretical rather than clinical. More data from other populations will help confirm.
Source:
Eur J Heart Fail 2025 (IRONMAN trial)”
Title: Effect of Correcting Iron Deficiency on the Risk of Serious Infection in Heart Failure: Insights from the IRONMAN Trial
Authors: Paul W. Foley, Paul R. Kalra, John G.F. Cleland, Mark C. Petrie, Philip A. Kalra, Ian Squire, Philip Campbell, Callum Chapman, Patrick Donnelly, Fraser Graham, Andrew Hannah, Ninian N. Lang, Iain Matthews, Stephen J. Leslie, Pierpaolo Pellicori, Sue Piper, Robin Ray, Hernry O. Savage, Chales Spencer, John Walsh, Yuk-Ki Wong, Ian Ford
Stay updated with Hemostasis Today.
-
May 10, 2026, 08:22Annie Bauzon: Why Every MLS Should Understand Blood Products
-
May 10, 2026, 08:11Waleed Zia: The Balance Between Bleeding and Thrombosis
-
May 10, 2026, 07:34Seema Dawood: Decoding Giant Platelets in Coagulation and Bone Marrow Disorders
-
May 10, 2026, 00:50Abdulla A. Damluji: Pulsed Field Ablation Delivers a New Standard for Persistent AF
-
May 10, 2026, 00:48Kirti Sharma: Immune Thrombocytopenia Market Set for Strong Growth Through 2036
-
May 10, 2026, 00:41Ram Chaganti: Could Immune Tolerance Be Engineered in Chronic Immune Thrombocytopenia?
-
May 9, 2026, 23:50Manuel Carbonell: Modern Phlebology Should Not Be a Competition of Devices and Technology
-
May 9, 2026, 23:37Maia Meier’s Journey: Raising Awareness for Women Living Without a Diagnosis – European Haemophilia Consortium
-
May 9, 2026, 23:13Aakanksha Angra: Building a Community for Advances in ALL